Detalhe da pesquisa
1.
O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology.
Nat Chem Biol
; 20(5): 646-655, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347213
2.
Top/Middle-Down Characterization of α-Synuclein Glycoforms.
Anal Chem
; 95(49): 18039-18045, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047498
3.
Author Correction: O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology.
Nat Chem Biol
; 20(5): 656, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413747
4.
Post-translational Modification of α-Synuclein Modifies Monomer Dynamics and Aggregation Kinetics.
bioRxiv
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766253
5.
O-GlcNAc Modification Alters the Chaperone Activity of HSP27 Charcot-Marie-Tooth Type 2 (CMT2) Variants in a Mutation-Selective Fashion.
ACS Chem Biol
; 18(8): 1705-1712, 2023 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540114
6.
O-GlcNAc modification forces the formation of an α-Synuclein amyloid-strain with notably diminished seeding activity and pathology.
bioRxiv
; 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945566
7.
Methods for Studying Site-Specific O-GlcNAc Modifications: Successes, Limitations, and Important Future Goals.
JACS Au
; 2(1): 74-83, 2022 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098223